Wednesday, October 2, 2024
HomeHealth ConditionsFibromyalgiaCBT: A potential insomnia therapy for fibromyalgia patients

CBT: A potential insomnia therapy for fibromyalgia patients

Researchers in the U.S. have recently conducted a study to examine the effects of cognitive behavioural therapy (CBT) on the brains of patients with fibromyalgia and insomnia.

There is a high prevalence of individuals who suffer from insomnia and chronic pain, with both occurring simultaneously in 50% to 80% of cases. This presents great challenges for both individuals and society due to the resulting health care costs and a decrease in quality of life. Sleep and pain can affect one another, as pain can decrease the amount of quality sleep obtained, and poor sleep can increase the level of pain.

Despite the apparent exchange between these two conditions, the degree to which they share causal factors is not well understood. Recently, much effort has been made to try and understand the causes of chronic pain and much of this investigation has concentrated on the central nervous system. Likewise, researchers have established hyperarousal as a factor which can develop and maintain insomnia.

Pain and sleep disturbance can often occur together, possibly because they both share a common neurophysiological pathway. Those with fibromyalgia are a suitable population to study both pain and insomnia, as most individuals with fibromyalgia suffer from sleep problems.

It has been shown from previous research that fibromyalgia and insomnia are associated with the shrinking, known as atrophy, of the grey matter within the brain. The preliminary results of this recent study demonstrate that CBT may be able to slow down this shrinking of the grey matter of the brain.

In a recent pilot study, researchers employed two types of CBT: CBT for Pain (CBT-P) and CBT for Insomnia (CBT-I). Overall, the results of the study showed those who received no CBT showed a thinning of the grey matter in the brain, while individuals who received CBT-P showed less shrinking of the brain during the same time period. Most interestingly, those who received CBT-I showed an increase in the thickness of the grey matter within the brain.

This pilot study, published in the Journal of Clinical Sleep Medicine, provides new and promising evidence that a CBT course as short as eight weeks may be sufficient to change the structure of the central nervous system of patients with fibromyalgia and insomnia. In addition to this, these preliminary results demonstrate that CBT-I is superior as it increases the thickness of the grey matter of the brain; CBT-P only attenuates the shrinking of the grey matter.

This pilot study serves to provide data which can provide a starting point for future research work that may lead to greater changes in structure and important changes in the experiences of sleep and pain. Future research work is required with larger numbers of patients and longer follow-ups, in order to establish the viability and limitations of this population and the robustness of these changes.

Written by Jade Marie Evans, MPharm, Medical Writer

Reference: McCrae, C.S. 2018. Gray Matter Changes Following Cognitive Behavioral Therapy for Patients With Comorbid Fibromyalgia and Insomnia: A Pilot Study. [Online]. [22 October 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134244/

Jade Evans MPharm
Jade Evans MPharm
Jade obtained her Master of Pharmacy degree from Cardiff University, UK in 2015 and then went on to work as a Pharmacist within the NHS, across both the hospital and community sectors. In 2017, she began her work for the medical news bulletin and moved to Perth, Australia. She is now working at Perth Children’s Hospital working in the Anaesthetic and Pain Management Research Group.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

ANKTIVA Boosts BCG for Bladder Cancer

The FDA has approved the immunotherapy-boosting drug, ANKTIVA, to be used with the existing immunotherapy drug, Bacillus Calmette-Guerin (BCG). This new therapy is a...

Joke Of The Day

Patient: Doctor, can you prescribe me something to stop me from sleepwalking? Doctor: No, you need the exercise!

ADVERTISE WITH US

error: Content is read-only and copy-protected.